North American Consortium for Histiocytosis

Academic/Hospital

Also known as: North American Consortium for Histiocytosis

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 1, 2014

Last known activity

Jan 31, 2021

Timeline

2010s

Jul 1, 2014
North American Consortium for Histiocytosis— Founded

Drugs by trial phase (14 distinct, 4 trials)

Phase 3 (9 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (5)

NCT04551131CollaboratorPhase 1/Phase 2Jan 31, 2021
NCT04079179CollaboratorPhase 2Aug 30, 2019
NCT02425904CollaboratorPhase 2May 1, 2015
NCT02205762Study chairPhase 2/Phase 3Jul 1, 2014
NCT02205762Lead sponsorPhase 2/Phase 3Jul 1, 2014

Details

Founded: Memphis, Tennessee, US Jul 1, 2014
Last known activity: Jan 31, 2021

Notes

No central headquarters, but it states that "St. Jude is the coordinating center for NACHO" (https://www.stjude.org/treatment/disease/histiocytosis/research.html) so I listed St. Jude's as the location